Projects

Mgr. Eliška Švastová, PhD.

National

Current
  • Alginate-based microcapsules with enhanced stability and biocompatibility for encapsulation of pancreatic islets in diabetes treatment
    Program: SRDA
    Duration: 1. 7. 2023 – 30. 6. 2027
  • Involvement of hypoxia-induced carbonic anhydrase IX in tumor cells-blood cells interaction during metastatic dissemination
    Program:
    Duration: 1. 8. 2024 – 30. 6. 2026
Finished
  • Cytokine profiling together with carbonic anhydrase IX immunotargeting as a promising tool in diagnostics and treatment of pancreatic cancer
    Program: SRDA
    Duration: 1. 7. 2021 – 30. 6. 2025
  • Effects of natural polyphenol and nonsteroidal anti-inflammatory drug combination therapy on the tumor microenvironment
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
  • Cell-in-cell phenomena as microevolutionary processes in cancer progression: a role for hypoxia-induced carbonic anhydrase IX
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • Strengthening of research, development and innovation capacities of translational biomedical research of human diseases
    Program:
    Duration: 1. 1. 2020 – 30. 6. 2023
  • Clinical evaluation of prognostic and predictive value of tissue and serum Carbonic Anhydrase IX in breast cancer
    Program: Other projects
    Duration: 1. 11. 2019 – 31. 12. 2022
  • Study of pro-metastatic functions of carbonic anhydrase IX, relationship between CA IX and mucins and hypoxic microenvironment in pancreatic cancer.
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2022
  • Biochips and biosensors for glycorecognition, their development, prepararion and application in cancer research
    Program: SRDA
    Duration: 1. 7. 2015 – 30. 6. 2019
  • Elucidation of novel pro-metastatic functions of tumor-associated carbonic anhydrase IX and its cross-talk with pro-inflammatory response
    Program: SRDA
    Duration: 1. 7. 2015 – 30. 6. 2019
  • Molecular pathways influenced by CA IX in hypoxic cancer cell lines
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2018
  • The role of hypoxia-induced carbonic anhydrase IX in invasion processes of tumor cells.
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2018
  • Carbonic anhydrase IX as a functional component of cancer progression: the role in epithelial-mesenchymal transition and intercellular signaling
    Program: SRDA
    Duration: 1. 7. 2012 – 31. 12. 2015
  • Regulation of carbonic anhydrase IX release and biological role of shed ectodomain in tumor cell-cell interactions
    Program: VEGA
    Duration: 1. 1. 2012 – 31. 12. 2015
  • -
    Program: EU Structural Funds Research & Development
    Duration: 1. 10. 2011 – 31. 10. 2015
  • The role of carbonic anhydrase IX in cell migration as a part of metastatic cascade.
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2014
  • Identification of the molecular pathways driven by hypoxia-induced carbonic anhydrase IX in tumor cells
    Program: SRDA
    Duration: 1. 5. 2011 – 31. 10. 2014
  • Complex approach to the investigation of cell migration and invasion in 2D and 3D environment with quantitative output
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2013
  • Biological properties and immunotherapeutic potential of the monoclonal antibodies specific for the tumor-associated protein CA IX
    Program: VEGA
    Duration: 1. 1. 2009 – 31. 12. 2011
Employees